Colorado health officials confirm two measles cases, release locations for potential exposures in Aurora and Colorado Springs
On Jun. 9, 2025, the Colorado Department of Public Health and Environment, the Arapahoe County Public Health Department,…
Colorado Department of Public Health Reported Second Potential Measles Case Identified
On Apr. 7, 2025, the Colorado Department of Public Health and Environment issued a Health Alert Network (HAN)…
Biotechnology | Diagnostics | Disease | Infectious Disease | Influenza | Vaccine | Veterinary | WHO
Mexico confirms country’s first human case of bird flu in 3-year-old girl
On Apr. 4, 2025, a 3-year-old girl from the western state of Durango is Mexico’s first confirmed human…
Colorado Department of Public Health Reported Additional Measles Exposure Locations
On Apr. 2, 2025, the Colorado Department of Public Health and Environment issued a Health Alert Network (HAN)…
The Colorado Department of Public Health identified Measles case in Pueblo County, Colorado
On Mar. 31, 2025, the Colorado Department of Public Health and Environment announced an unvaccinated adult in Colorado…
Texas Officials Encouraged Monitoring, Reporting of Animals Affected by New World Screwworm
On Dec. 30, 2024, Texas Parks and Wildlife Department (TPWD) asked hunters and other outdoor enthusiasts in South…
United States Prevailed in U.S., Mexico Dispute on Biotech Corn
In Dec. 20, 2024, the United States Trade Representative announced that the United States has prevailed in its…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
USDA Approved Emergency Funding to Protect U.S. Livestock and Animals from New World Screwworm
On Dec. 13, 2024, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) announced $165…
PAHO highlights increase in dengue, Oropouche, and avian influenza cases in the Americas, control measures advised
On Dec. 10, 2024, the Pan American Health Organization (PAHO) reported on three transmissible diseases affecting the Region…
genomic origin of early maize in eastern North America reaveled
On Dec. 4, 2024, an international team of scientists led by the Center for Evolutionary Hologenomics, GLOBE Institute,…
U.S. suspended Mexican cattle imports after New World screwworm case
On Nov. 26, 2024, the U.S. Department of Agriculture (USDA) announced it had temporarily paused imports of Mexican…
Mexico Notified United States of New World Screwworm Detection
On Nov. 22, 2024, the Chief Veterinary Officer of Mexico notified the U.S. Department of Agriculture’s (USDA) Animal…
WHO reported Person with bird flu died in Mexico
On Jun. 5, 2024, the World Health Organization (WHO) reported that a person with prior health complications who…
CDC announced Rocky Mountain spotted fever in people traveling to the U.S. from Tecate, Mexico
On Dec. 11, 2023, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network…
Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
Highly pathogenic avian influenza confirmed as cause of three California condor mortalities in Arizona
On Apr. 7, 2023, the U.S. National Park Service reported Highly Pathogenic Avian Influenza (HPAI) had been confirmed…
Swissmedic granted conditional Marketing Authorization for Novavax COVID-19 vaccine
On Apr. 13, 2022, Novavax announced that Swissmedic had granted Novavax conditional marketing authorization (CMA) for Nuvaxovid COVID-19…
Biotechnology | COVID-19 | FDA | Therapeutics
Sorrento announced FDA authorization to proceed with phase 1 study of Intranasal STI-9199 against Covid-19 viruses
On Mar. 2, 2022, Sorrento Therapeutics announced that it had received clearance from the FDA for its investigational…
Moderna expanded global footprint through commercial partnership with Adium in Latin America
On Feb. 22, 2022, Moderna announced a distribution service agreement with Adium Pharma, a leading private Latin American…
Novavax files for conditional Marketing Authorization of COVID-19 vaccine in Switzerland
On Feb. 14, 2022, Novavax announced its submission to Swissmedic, the Swiss Agency for Therapeutic Products, for conditional…
Novavax submitted request to U.S. FDA for Emergency Use Authorization of COVID-19 vaccine
On Jan. 31, 2022, Novavax announced that it had submitted a request to the U.S Food and Drug…
Sorrento announced COVISTIX COVID-19 virus rapid antigen detection test detected the Omicron variant
On Dec. 27, 2021, Sorrento Therapeutics announced that initial testing of COVISTIX on recombinant N proteins demonstrated its…
Novavax filed for Emergency Use of COVID-19 vaccine in the United Arab Emirates
On Dec. 13, 2021, Novavax announced that it had submitted a regulatory filing to the Ministry of Health…
Novavax filed for interim authorization of COVID-19 vaccine in singapore
On Nov. 24, 2021, Novavax announced its submission to the Singapore Health Sciences Authority for interim authorization of…
INOVIO further expanded INNOVATE phase 3 trial for COVID-19 DNA vaccine candidate INO-4800 in India
On Nov. 3, 2021, Inovio Pharma announced that it had received authorization from India’s Central Drugs Standard Control…
Novavax filed COVID-19 vaccine for provisional approval in New Zealand
On Nov. 3, 2021, Novavax announced the company had filed for provisional approval of the vaccine to the…
INOVIO expanded INNOVATE phase 3 for INO-4800 to include Colombia
On Oct. 11, 2021, Inovio Pharmaceuticals announced that it had received authorization from Colombia’s INVIMA, to conduct the…
INOVIO received regulatory authorization to conduct phase 3 efficacy trial of COVID-19 DNA vaccine candidate in Mexico
On Sept. 22, 2021, Inovio Pharmaceuticals announced that it had received authorization from COFEPRIS, the national health regulatory…
Novavax and EC finalized advance purchase agreement for up to 200 million doses of COVID-19 vaccine
On Aug. 4, 2021, Novavax announced that it had reached an agreement with the European Commission (EC) for…
Novavax COVID-19 vaccine demonstrated 90% overall efficacy and 100% protection in phase 3 trial
On Jun. 14, 2021, Novavax announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against…